Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Amyloidosis

Known as: Amyloidosis NOS, AMYLOID, amyloid diseases 
A group of diseases in which protein builds up in certain organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis… Expand
National Institutes of Health

Related topics

Related topics

48 relations
2 ML Digoxin 0.25 MG/ML InjectionAcetylcysteineAcetylcysteine 200 MG/ML Inhalant SolutionAmyloid
Expand

Narrower (14)

AMYLOIDOSIS, HEREDITARY, CARDIOPATHICAMYLOIDOSIS, SECONDARY GENERALIZEDAmyloid Neuropathies, FamilialAmyloidosis, Primary Cutaneous
Expand

Broader (2)

Inborn Errors of MetabolismMetabolic Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European…
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) over the last 25 years, most… Expand
Is this relevant?
Review
2019
Review
2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Rationale & ObjectiveThe approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including… Expand
Is this relevant?
Review
2018
Review
2018
Evans Blue Dye: A Revisit of Its Applications in Biomedicine
Evans blue (EB) dye has owned a long history as a biological dye and diagnostic agent since its first staining application by… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Review
2017
Review
2017
Pathology of Neurodegenerative Diseases.
Neurodegenerative disorders are characterized by progressive loss of selectively vulnerable populations of neurons, which… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
BACKGROUND Transthyretin amyloidosis is caused by the deposition of hepatocyte-derived transthyretin amyloid in peripheral nerves… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Natural history and outcome in systemic AA amyloidosis.
BACKGROUND Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2005
Review
2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis
Oxidative stress is a key feature in the Alzheimer's disease (AD) brain and manifests as lipid peroxidation (LPO). Isoprostanes… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Common core structure of amyloid fibrils by synchrotron X-ray diffraction.
Tissue deposition of normally soluble proteins as insoluble amyloid fibrils is associated with serious diseases including the… Expand
  • figure 5.25
  • figure 5.25
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Advanced glycation end products contribute to amyloidosis in Alzheimer disease.
Alzheimer disease (AD) is characterized by deposits of an aggregated 42-amino-acid beta-amyloid peptide (beta AP) in the brain… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE